Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session.
Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.
Oral presentation evaluating feasibility of BgRT using long-lived immune PET tracer awarded Best in Physics HAYWARD, Calif., July 11, 2022 – RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced that researchers will present new data from 14 medical physics investigations validating the efficacy […]
More than a decade ago, Sam Mazin and his best friend Akshay Nanduri were spending long hours over many months huddled together in Mazin’s apartment trying to figure out if they could build a machine that would treat cancer in a new way. When they realized they might be able to, they founded RefleXion Medical. […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.